Zydus Cadila developed vaccine for children in age group of 5 to 12, expected to be approved by July

Zykov-D for childrens

New Delhi: Ahmedabad-based Zydus Cadila group is planning to test its vaccine for coronavirus (ZyKov-D) for children between 5 and 12 years of age. Zykov-D is a plasmid DNA vaccine, which is under the nucleic acid vaccine. Recently, Zydus Cadila has conducted 800 clinical trials for adults, while the vaccine has also been tested for children between 12 and 18 years old.

The company’s preparation is to get approval to use emergency for its vaccine by the end of June or July. In a conversation with The Times of India, Managing Director of Cadila Healthcare Limited said, “We will have a good amount of data on vaccine testing on children aged 5 to 12. If everything goes well, then 12 The vaccine will be approved for 18-year-olds. “

The vaccine will be more beneficial for children
Patel said, “The development of the vaccine is always in stages, first for seniors, then for children and then for children younger than 5 years. Our vaccine will be more beneficial for children. There will be no side effects.” . As is commonly seen in other vaccines. Another advantage of this vaccine is that it does not require injection. “

Zykov-D for childrens

Recently, Zydus Cadila has sought permission from the Drug Controller General of India for a human clinical trial of a monoclonal antibodies cocktail for the treatment of corona virus. Cadila Healthcare stated in its regulatory filing that “Zydus is awaiting approval from DCGI for a Phase III clinical trial of the ZRC-3308 vaccine of the corona virus.” This vaccine is a cocktail of two monoclonal antibodies to the corona virus.

Zydus has stated that Cadila Healthcare is the only company in India to develop a cocktail-based monoclonal antibody to kill the corona virus.